Safety and Immunogenicity of the Candidate Vaccine MVA-SARS-2-S and a Booster Vaccination With a Licensed Vaccine Against COVID-19
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04569383 |
Recruitment Status :
Completed
First Posted : September 29, 2020
Last Update Posted : November 5, 2021
|
Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Collaborators:
German Center for Infection Research
Philipps University Marburg Medical Center
Ludwig-Maximilians - University of Munich
Information provided by (Responsible Party):
Universitätsklinikum Hamburg-Eppendorf
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | August 24, 2021 |
Actual Study Completion Date : | August 24, 2021 |